Olmiwake 40AM Tablet
Images are for reference. Actual packaging may vary.
Olmesartan Medoxomil (40mg) + Amlodipine (5mg)
Strip of 10 tablets • Tablet
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+1 more active ingredient
Amlodipine inhibits calcium ion influx into vascular smooth muscle and cardiac muscle, leading to vasodilation and reduced myocardial oxygen demand.
Olmesartan Medoxomil blocks angiotensin II receptors, preventing vasoconstriction and lowering blood pressure.
Medical applications
Olmiwake 40AM Tablet is a combination antihypertensive medication containing Olmesartan Medoxomil 40 mg and Amlodipine 5 mg. Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB) that selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby reducing vasoconstriction and aldosterone secretion, leading to decreased blood pressure. Amlodipine, a dihydropyridine calcium channel blocker, inhibits the influx of calcium ions into vascular smooth muscle and cardiac muscle, promoting vasodilation and reducing peripheral vascular resistance.
The synergistic action of these two agents effectively manages hypertension by targeting different physiological pathways, improving blood pressure control in patients inadequately responsive to monotherapy. Olmiwake 40AM is indicated for the treatment of essential hypertension and may reduce the risk of cardiovascular events associated with high blood pressure. It is generally well tolerated, with common adverse effects including dizziness, peripheral edema, and headache.
Caution is advised in patients with severe hepatic or renal impairment, and it is contraindicated during pregnancy. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during treatment. Olmiwake 40AM should be used under medical supervision, adhering to prescribed dosages to optimize therapeutic outcomes and minimize potential risks.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Olmiwake 40AM Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Olmiwake 40AM Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Olmiwake 40AM Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Olmiwake 40AM Tablet may be needed. Please consult your doctor. Regular monitoring of blood pressure is advisable for dose adjustment.
Exercise Caution
Olmiwake 40AM Tablet may cause side effects which could affect your ability to drive. Olmiwake 40AM Tablet may cause side effects such as dizziness, headaches, nausea or tiredness, all of which could affect your ability to concentrate and drive.
Consult Doctor
Olmiwake 40AM Tablet should be used with caution in patients with liver disease. Dose adjustment of Olmiwake 40AM Tablet may be needed. Please consult your doctor. Olmiwake 40AM Tablet is started at a lower dose in patients with liver disease and further increased slowly with careful monitoring.
Regular Checkup
0 reviews for Olmiwake 40AM Tablet






